
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 991 | 975 | 906 | 1210 | 1784 |
Fund Return | 3.81% | -0.88% | -2.5% | -3.23% | 3.88% | 5.96% |
Place in category | 30 | 52 | 110 | 87 | 65 | 18 |
% in Category | 23 | 46 | 86 | 72 | 64 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Oppenheimer Main Street A | 8.74B | 2.34 | 10.43 | 11.12 | ||
Oppenheimer Developing Markets Y | 7.82B | 1.76 | -1.74 | 2.18 | ||
Oppenheimer Global A | 5.56B | 1.85 | 8.59 | 9.11 | ||
Oppenheimer Developing Markets I | 5.13B | 1.79 | -1.59 | 2.34 | ||
Oppenheimer Capital Appreciation A | 4.51B | -2.05 | 11.98 | 12.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS International New Discovery R6 | 4.94B | 1.92 | 1.31 | 4.72 | ||
Fidelity Series International Sm C | 3.82B | 3.58 | 3.68 | 7.33 | ||
T. Rowe Price International Discove | 3.46B | 2.00 | -0.83 | - | ||
Artisan International Small Cap Ins | 3.11B | 1.49 | -0.40 | - | ||
T. Rowe Price International Discov | 1.98B | 1.99 | -0.98 | 6.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Carl Zeiss AG | DE0005313704 | 2.59 | 60.600 | -7.76% | |
Obic Co Ltd | JP3173400007 | 2.42 | 4,309.0 | -0.58% | |
Partners Group | CH0024608827 | 2.18 | 1,254.50 | -2.86% | |
Azbil Corp | JP3937200008 | 1.70 | 1,151.5 | -4.52% | |
ChemoMetec | DK0060055861 | 1.60 | 492.60 | -3.41% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Neutral | Strong Sell |
Summary | Strong Sell | Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review